Mechanically, TFAP2A could regulate CES3 levels in NSCLC, that the dysregulation of TFAP2A resulted in CES3 overexpression and the following NSCLC tumorigenesis. The gene discussed is CES3; the disease is non-small cell lung carcinoma.